查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108333

生物技術市場分析及預測（至2035年）：依類型、產品、服務、技術、組件、應用、製程、最終用戶及功能分類

Biotechnology Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球生技市場預計將從2025年的1.5兆美元成長到2035年的4.3兆美元，複合年成長率（CAGR）為11.0%。這一成長主要得益於全球研究活動的活性化、基因組相關舉措的擴展以及生物技術解決方案在醫療保健、農業和工業領域的日益普及。據美國國家人類基因組研究所（NHGRI）稱，人類基因組定序的成本已大幅下降至1,000美元以下，加速了基因組研究、精準醫療和生物技術應用的發展。合成生物學、生物資訊學和分子工程領域的進步也進一步推動了創新和市場成長。

生物技術市場的「類型」細分包括紅色生物技術、綠色生物技術、白色生物技術、藍色生物技術、生物資訊學、基因組學、蛋白質組學、代謝體學和合成生物學。其中，紅色生物技術憑藉其在醫療保健領域的廣泛應用（包括生物製藥生產、基因治療、疫苗和先進診斷），佔了較大的市場佔有率。合成生物學、基因組學和生物資訊學正經歷著快速成長，這得益於分子研究、精準醫療和數據驅動的生物分析的進步。綠色生物技術和白色生物技術也不斷擴大規模，在永續農業、生物基化學品、工業酵素和可再生解決方案等領域的應用日益廣泛。生物技術平台的持續創新正在進一步加速各產業新產品和新應用的開發。

市場區隔
類型 紅色生物技術、綠色生物技術、白色生物技術、藍色生物技術、生物資訊學、基因體學、蛋白質體學、代謝體學、合成生物學等。
產品 生物製藥、生物資訊工具、生質燃料、生物農藥、生質塑膠、基因改造作物、診斷試劑、酵素、細胞培養系統等。
服務 合約研究、契約製造、諮詢服務、法規遵循、臨床試驗、化驗服務、生物銀行、基因檢測、生物製程等。
科技 DNA定序、奈米生物技術、組織工程、基因編輯、微陣列技術、PCR技術、層析法、光譜學、反應器等。
成分 試劑、試劑盒、儀器、軟體、耗材、生物樣本、細胞株、載體、抗體等。
目的 醫療保健、農業、工業加工、環境生物技術、食品和飲料、生物安全、海洋生物技術、生物防禦、動物生物技術等。
流程 上游製程、下游製程、發酵、純化、配方、放大、品管、生物製程最佳化、生物製程監測等。
最終用戶 製藥公司、生技公司、研究機構、醫院和診所、農業部門、環保組織、食品和飲料業、學術機構、政府機構等。
功能 治療、診斷、預防、研究、生產、分析、監測、控制、最佳化等。

生物技術市場的應用領域包括醫療保健、農業、工業加工、環境生物技術、食品飲料、生物安全、海洋生物技術、生物防禦和動物生物技術。醫療保健是主要的應用領域，這得益於對生物製劑、個人化醫療、再生醫學和分子診斷日益成長的需求。在農業領域，隨著基改作物、生物農藥和改良育種技術的應用，生物技術的重要性日益凸顯，這些技術有助於提高生產力和永續性。在工業加工領域，生物技術在生質燃料、酵素和生物基材料方面的應用正在推動市場擴張。環境生物技術、食品生物技術和動物生物技術也因人們日益關注永續解決方案、食品安全以及生物過程的改進而蓬勃發展。

區域概覽

到2025年，北美將佔全球生物技術市場最大佔有率，這得益於其高度發展的生命科學生態系統、強大的製藥和生物技術產業以及對研發的大量投入。該地區匯聚了許多領先的生物技術公司、研究型大學和受託研究機構積極推動生物製藥、基因和細胞療法、精準醫療、合成生物學和分子診斷等領域的發展。慷慨的政府資助、有利的法規環境以及活躍的創業投資投資正在加速生物技術產品的創新和商業化。此外，生物技術公司、製藥公司和學術機構之間日益深化的合作將繼續鞏固北美在全球生物技術市場的領先地位。

亞太地區預計將成為生物技術市場成長最快的地區，這主要得益於生物製藥生產的擴張、政府對生物技術創新的大力支持以及對基因組學、再生醫學和精準醫療領域投資的增加。中國、印度、日本、韓國和新加坡等國家正透過國家研究計畫、完善的實驗室基礎設施以及對國內生物製藥生產的獎勵來增強其生物技術能力。除了對生物製藥、生物相似藥、疫苗和先進診斷產品日益成長的需求外，臨床研究活動和契約製造服務的擴展也進一步推動了市場成長。此外，全球生技公司與區域研究機構之間合作的不斷加強，以及龐大的患者群體和不斷完善的醫療基礎設施，使得亞太地區在預測期內成為成長最快的區域市場。

主要趨勢和促進因素

人工智慧（AI）與先進生物技術的融合發展

生物技術市場正呈現出強勁的趨勢，即整合人工智慧（AI）、合成生物學和多體學技術以加速研發和創新。生物技術公司正擴大利用人工智慧平台進行藥物發現、蛋白質工程、生物標記識別和生物過程最佳化。基因編輯、細胞工程和計算生物學的進步正在推動下一代療法的開發，包括基因療法、細胞療法和個人化醫療。此外，自動化和數位化技術在生物技術研發和生產中的應用，正在提高效率、縮短研發週期，並增強製藥、農業和工業生物技術領域的規模化生產能力。

對先進療法和個人化醫療的需求日益成長

對包括生物製藥、細胞和基因療法以及精準醫療在內的創新療法的需求日益成長，是生物技術市場的主要驅動力。癌症、遺傳性疾病、自體免疫疾病和慢性疾病的日益普遍，促使人們迫切需要標靶性強、療效顯著的治療方案。製藥和生技公司正在加大研發投入，以發現新的療法並改善患者的治療效果。此外，分子生物學、基因組學和再生醫學的進步也為突破性療法的開發提供了支持。醫療保健領域的投資增加、政府對生物技術研究的資助以及生物製藥生產能力的擴大，都在進一步加速全球市場的成長。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 紅色生物技術
    • 綠色生物技術
    • 白色生物技術
    • 藍色生物技術
    • 生物資訊學
    • 基因組學
    • 蛋白質體學
    • 代謝體學
    • 合成生物學
    • 其他
  • 市場規模及預測：依產品分類
    • 生物製藥
    • 生物資訊學工具
    • 生質燃料
    • 生物農藥
    • 生質塑膠
    • 基因改造作物
    • 診斷試劑
    • 酵素
    • 細胞培養系統
    • 其他
  • 市場規模及預測：依服務分類
    • 合約研究
    • 契約製造
    • 諮詢服務
    • 監理合規
    • 臨床試驗
    • 化驗服務
    • 生物銀行
    • 基因檢測
    • 生物製程
    • 其他
  • 市場規模及預測：依技術分類
    • DNA定序
    • 奈米生物技術
    • 組織工程
    • 基因編輯
    • 微陣列技術
    • PCR技術
    • 層析法
    • 光譜學
    • 反應器
    • 其他
  • 市場規模及預測：依應用領域分類
    • 衛生保健
    • 農業
    • 工業加工
    • 環境生物技術
    • 飲食
    • 生物安全
    • 海洋生物技術
    • 生物防禦
    • 動物生物技術
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生技公司
    • 研究機構
    • 醫院和診所
    • 農業部門
    • 環保組織
    • 食品飲料業
    • 學術機構
    • 政府機構
    • 其他
  • 市場規模及預測：依製程分類
    • 上游工藝
    • 下游工藝
    • 發酵
    • 純化
    • 配方
    • 擴大規模
    • 品管
    • 生物製程最佳化
    • 生物過程監測
    • 其他
  • 市場規模及預測：依組件分類
    • 試劑
    • 成套工具
    • 裝置
    • 軟體
    • 消耗品
    • 生物樣本
    • 細胞株
    • 向量
    • 抗體
    • 其他
  • 市場規模及預測：依功能分類
    • 治療
    • 診斷
    • 預防
    • 研究
    • 生產
    • 分析
    • 監測
    • 控制
    • 最佳化
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Roche
  • Amgen
  • Gilead Sciences
  • Biogen
  • Regeneron Pharmaceuticals
  • Vertex Pharmaceuticals
  • Moderna
  • Illumina
  • BioNTech
  • Genmab
  • CRISPR Therapeutics
  • Novavax
  • Alnylam Pharmaceuticals
  • Sarepta Therapeutics
  • Incyte
  • Seagen
  • Ionis Pharmaceuticals
  • Bluebird Bio
  • Beam Therapeutics
  • Editas Medicine

第9章 關於我們

簡介目錄
Product Code: GIS10086

The global Biotechnology Market is projected to grow from $1.5 trillion in 2025 to $4.3 trillion by 2035, at a compound annual growth rate (CAGR) of 11.0%. The biotechnology market is supported by increasing global research activity, expanding genomic initiatives, and growing adoption of biotechnology solutions across healthcare, agriculture, and industrial applications. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has declined dramatically, reaching below the $1,000 range, enabling broader adoption of genomic research, precision medicine, and biotechnology applications. Advancements in synthetic biology, bioinformatics, and molecular engineering are further accelerating innovation and market growth.

The Type segment of the Biotechnology Market includes red biotechnology, green biotechnology, white biotechnology, blue biotechnology, bioinformatics, genomics, proteomics, metabolomics, synthetic biology, and others. Among these, red biotechnology holds a significant market share due to its extensive applications in healthcare, including biopharmaceutical production, gene therapies, vaccines, and advanced diagnostics. Synthetic biology, genomics, and bioinformatics are witnessing rapid growth due to advancements in molecular research, precision medicine, and data-driven biological analysis. Green and white biotechnology are also expanding with increasing adoption in sustainable agriculture, bio-based chemicals, industrial enzymes, and renewable solutions. Continuous innovation in biotechnology platforms is further accelerating the development of novel products and applications across industries.

Market Segmentation
TypeRed Biotechnology, Green Biotechnology, White Biotechnology, Blue Biotechnology, Bioinformatics, Genomics, Proteomics, Metabolomics, Synthetic Biology, Others
ProductBiopharmaceuticals, Bioinformatics Tools, Biofuels, Biopesticides, Bioplastics, Genetically Modified Crops, Diagnostic Reagents, Enzymes, Cell Culture Systems, Others
ServicesContract Research, Contract Manufacturing, Consulting Services, Regulatory Compliance, Clinical Trials, Laboratory Services, Biobanking, Genetic Testing, Bioprocessing, Others
TechnologyDNA Sequencing, Nanobiotechnology, Tissue Engineering, Gene Editing, Microarray Technology, PCR Technology, Chromatography, Spectroscopy, Bioreactors, Others
ComponentReagents, Kits, Instruments, Software, Consumables, Biological Samples, Cell Lines, Vectors, Antibodies, Others
ApplicationHealthcare, Agriculture, Industrial Processing, Environmental Biotechnology, Food and Beverage, Biosecurity, Marine Biotechnology, Biodefense, Animal Biotechnology, Others
ProcessUpstream Processing, Downstream Processing, Fermentation, Purification, Formulation, Scale-up, Quality Control, Bioprocess Optimization, Bioprocess Monitoring, Others
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Hospitals and Clinics, Agricultural Sector, Environmental Agencies, Food and Beverage Industry, Academic Institutions, Government Organizations, Others
FunctionalityTherapeutic, Diagnostic, Preventive, Research, Production, Analytical, Monitoring, Control, Optimization, Others

The Application segment of the Biotechnology Market includes healthcare, agriculture, industrial processing, environmental biotechnology, food and beverage, biosecurity, marine biotechnology, biodefense, animal biotechnology, and others. Healthcare represents the leading application area due to rising demand for biologics, personalized medicine, regenerative therapies, and molecular diagnostics. Agriculture is gaining importance with the adoption of genetically modified crops, biopesticides, and improved breeding technologies to enhance productivity and sustainability. Industrial processing is expanding through the use of biotechnology for biofuels, enzymes, and bio-based materials. Environmental biotechnology, food biotechnology, and animal biotechnology are also witnessing growth due to increasing focus on sustainable solutions, food security, and improved biological processes.

Geographical Overview

North America held the largest share of the global biotechnology market in 2025, driven by its highly developed life sciences ecosystem, strong pharmaceutical and biotechnology industries, and substantial investments in research and development. The region is home to leading biotechnology companies, research universities, and contract research organizations that are actively advancing biologics, gene and cell therapies, precision medicine, synthetic biology, and molecular diagnostics. Robust government funding, a favorable regulatory environment, and strong venture capital investment have accelerated innovation and commercialization of biotechnology products. Furthermore, increasing collaborations between biotechnology firms, pharmaceutical companies, and academic institutions continue to strengthen North America's leadership in the global biotechnology market.

Asia Pacific is expected to register the highest growth in the biotechnology market due to expanding biopharmaceutical manufacturing, increasing government support for biotechnology innovation, and rising investments in genomics, regenerative medicine, and precision healthcare. Countries such as China, India, Japan, South Korea, and Singapore are strengthening their biotechnology capabilities through national research programs, improved laboratory infrastructure, and incentives for domestic biopharmaceutical production. Growing demand for biologics, biosimilars, vaccines, and advanced diagnostics, along with expanding clinical research activities and contract manufacturing services, is further driving market expansion. Moreover, increasing partnerships between global biotechnology companies and regional research institutions, coupled with a large patient population and improving healthcare infrastructure, are expected to position Asia Pacific as the fastest-growing regional market during the forecast period.

Key Trends and Drivers

Increasing Integration of Artificial Intelligence and Advanced Biotechnologies:

The Biotechnology Market is witnessing a strong trend toward the integration of artificial intelligence (AI), synthetic biology, and multi-omics technologies to accelerate research and innovation. Biotechnology companies are increasingly using AI-driven platforms for drug discovery, protein engineering, biomarker identification, and optimization of biological processes. Advances in gene editing, cell engineering, and computational biology are enabling the development of next-generation therapeutics, including gene therapies, cell therapies, and personalized medicines. Additionally, the adoption of automation and digital technologies in biotechnology research and manufacturing is improving efficiency, reducing development timelines, and enhancing scalability across pharmaceutical, agricultural, and industrial biotechnology applications.

Growing Demand for Advanced Therapeutics and Personalized Medicine:

The increasing demand for innovative therapeutics, including biologics, cell and gene therapies, and precision medicines, is a major driver of the Biotechnology Market. Rising incidences of cancer, genetic disorders, autoimmune diseases, and chronic conditions are increasing the need for targeted and effective treatment solutions. Pharmaceutical and biotechnology companies are expanding investments in research and development to discover novel therapies and improve patient outcomes. Furthermore, advancements in molecular biology, genomics, and regenerative medicine are supporting the development of breakthrough treatments. Growing healthcare investments, government funding for biotechnology research, and expansion of biopharmaceutical manufacturing capabilities are further accelerating market growth globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Component
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Red Biotechnology
    • 4.1.2 Green Biotechnology
    • 4.1.3 White Biotechnology
    • 4.1.4 Blue Biotechnology
    • 4.1.5 Bioinformatics
    • 4.1.6 Genomics
    • 4.1.7 Proteomics
    • 4.1.8 Metabolomics
    • 4.1.9 Synthetic Biology
    • 4.1.10 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Biopharmaceuticals
    • 4.2.2 Bioinformatics Tools
    • 4.2.3 Biofuels
    • 4.2.4 Biopesticides
    • 4.2.5 Bioplastics
    • 4.2.6 Genetically Modified Crops
    • 4.2.7 Diagnostic Reagents
    • 4.2.8 Enzymes
    • 4.2.9 Cell Culture Systems
    • 4.2.10 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Contract Research
    • 4.3.2 Contract Manufacturing
    • 4.3.3 Consulting Services
    • 4.3.4 Regulatory Compliance
    • 4.3.5 Clinical Trials
    • 4.3.6 Laboratory Services
    • 4.3.7 Biobanking
    • 4.3.8 Genetic Testing
    • 4.3.9 Bioprocessing
    • 4.3.10 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 DNA Sequencing
    • 4.4.2 Nanobiotechnology
    • 4.4.3 Tissue Engineering
    • 4.4.4 Gene Editing
    • 4.4.5 Microarray Technology
    • 4.4.6 PCR Technology
    • 4.4.7 Chromatography
    • 4.4.8 Spectroscopy
    • 4.4.9 Bioreactors
    • 4.4.10 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Healthcare
    • 4.5.2 Agriculture
    • 4.5.3 Industrial Processing
    • 4.5.4 Environmental Biotechnology
    • 4.5.5 Food and Beverage
    • 4.5.6 Biosecurity
    • 4.5.7 Marine Biotechnology
    • 4.5.8 Biodefense
    • 4.5.9 Animal Biotechnology
    • 4.5.10 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical Companies
    • 4.6.2 Biotechnology Companies
    • 4.6.3 Research Institutes
    • 4.6.4 Hospitals and Clinics
    • 4.6.5 Agricultural Sector
    • 4.6.6 Environmental Agencies
    • 4.6.7 Food and Beverage Industry
    • 4.6.8 Academic Institutions
    • 4.6.9 Government Organizations
    • 4.6.10 Others
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Upstream Processing
    • 4.7.2 Downstream Processing
    • 4.7.3 Fermentation
    • 4.7.4 Purification
    • 4.7.5 Formulation
    • 4.7.6 Scale-up
    • 4.7.7 Quality Control
    • 4.7.8 Bioprocess Optimization
    • 4.7.9 Bioprocess Monitoring
    • 4.7.10 Others
  • 4.8 Market Size & Forecast by Component (2020-2035)
    • 4.8.1 Reagents
    • 4.8.2 Kits
    • 4.8.3 Instruments
    • 4.8.4 Software
    • 4.8.5 Consumables
    • 4.8.6 Biological Samples
    • 4.8.7 Cell Lines
    • 4.8.8 Vectors
    • 4.8.9 Antibodies
    • 4.8.10 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Therapeutic
    • 4.9.2 Diagnostic
    • 4.9.3 Preventive
    • 4.9.4 Research
    • 4.9.5 Production
    • 4.9.6 Analytical
    • 4.9.7 Monitoring
    • 4.9.8 Control
    • 4.9.9 Optimization
    • 4.9.10 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Component
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Component
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Component
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Component
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Component
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Component
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Component
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Component
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Component
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Component
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Component
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Component
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Component
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Component
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Component
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Component
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Component
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Component
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Component
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Component
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Component
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Component
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Component
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Component
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Roche
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Amgen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Gilead Sciences
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Biogen
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Regeneron Pharmaceuticals
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Vertex Pharmaceuticals
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Moderna
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Illumina
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 BioNTech
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Genmab
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 CRISPR Therapeutics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Novavax
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Alnylam Pharmaceuticals
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Sarepta Therapeutics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Incyte
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Seagen
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ionis Pharmaceuticals
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bluebird Bio
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Beam Therapeutics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Editas Medicine
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us